Author details

Full Name

Jacqueline Snider

Affiliation

ORCID

Career Start Year

1998

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33989287	A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.	PLoS One	2021
31432366	Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.	Breast Cancer Res Treat	2019
30181556	The prognostic effects of somatic mutations in ER-positive breast cancer.	Nat Commun	2018
30429476	Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.	Nat Commun	2018
27993329	An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.	J Mol Diagn	2017
28348404	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
28440318	Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
29124938	Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.	J Proteome Res	2017
27502118	Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.	Nat Commun	2016
28691057	PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).	NPJ Breast Cancer	2016
26297356	Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.	BMC Med Genomics	2015
24719451	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.	Mol Cell Proteomics	2014
25357113	Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.	Arch Pathol Lab Med	2014
22722193	Whole-genome analysis informs breast cancer response to aromatase inhibition.	Nature	2012
21555689	Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.	J Clin Oncol	2011
19844788	Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.	Breast Cancer Res Treat	2010
20837693	A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.	Clin Cancer Res	2010
20393555	Genome remodelling in a basal-like breast cancer metastasis and xenograft.	Nature	2010
19567831	Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.	Proc Natl Acad Sci U S A	2009
19366795	PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.	Cancer Res	2009
19436038	Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.	J Natl Cancer Inst	2009
16128592	Submicromolar concentrations of palmitoyl-CoA specifically thioesterify cysteine 244 in glyceraldehyde-3-phosphate dehydrogenase inhibiting enzyme activity: a novel mechanism potentially underlying fatty acid induced insulin resistance.	Biochemistry	2005
15815621	Generation and annotation of the DNA sequences of human chromosomes 2 and 4.	Nature	2005
10738668	Modification of a commercially available DNA sequencer to increase sample throughput.	IEEE Eng Med Biol Mag	2000
9582197	A pneumatic device for rapid loading of DNA sequencing gels.	Genome Res	1998